Feda E. Mohamed

Al Ain, AZ, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase.

Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase.

Journal: International journal of molecular sciences

Published: March 13, 2025

The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.

The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.

Journal: Journal of biomedical science

Published: March 24, 2024

Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies.

Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies.

Journal: Frontiers in pharmacology

Published: November 08, 2023

Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (Mpro) through pharmacophore modelling, covalent docking, and biological evaluation.

Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (Mpro) through pharmacophore modelling, covalent docking, and biological evaluation.

Journal: Journal of molecular graphics & modelling

Published: September 15, 2023

The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro ).

The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro ).

Journal: Chemistry & biodiversity

Published: August 07, 2023

Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families.

Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families.

Journal: Orphanet journal of rare diseases

Published: June 13, 2023

Novel compound heterozygous variants (c.971delA/c.542C > T) in SLC1A4 causes spastic tetraplegia, thin corpus callosum, and progressive microcephaly: a case report and mutational analysis.

Novel compound heterozygous variants (c.971delA/c.542C > T) in SLC1A4 causes spastic tetraplegia, thin corpus callosum, and progressive microcephaly: a case report and mutational analysis.

Journal: Frontiers in pediatrics

Published: March 10, 2023

Genetic disruption of mammalian endoplasmic reticulum-associated protein degradation: Human phenotypes and animal and cellular disease models.

Genetic disruption of mammalian endoplasmic reticulum-associated protein degradation: Human phenotypes and animal and cellular disease models.

Journal: Traffic (Copenhagen, Denmark)

Published: March 02, 2023

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation.

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: August 31, 2022

Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking.

Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking.

Journal: Human genomics

Published: February 10, 2022

A Type 3 Gaucher-Like Disease Due To Saposin C Deficiency in Two Emirati Families Caused by a Novel Splice Site Variant in the PSAP Gene.

A Type 3 Gaucher-Like Disease Due To Saposin C Deficiency in Two Emirati Families Caused by a Novel Splice Site Variant in the PSAP Gene.

Journal: Journal of molecular neuroscience : MN

Published: January 24, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026